Aditxt

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aditxt and other ETFs, options, and stocks.

About ADTX

Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. 

CEO
Amro Albanna
CEOAmro Albanna
Employees
26
Employees26
Headquarters
Mountain View, California
HeadquartersMountain View, California
Founded
2017
Founded2017
Employees
26
Employees26

ADTX Key Statistics

Market cap
410.69K
Market cap410.69K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
256.18K
Average volume256.18K
High today
$0.7598
High today$0.7598
Low today
$0.7108
Low today$0.7108
Open price
$0.72
Open price$0.72
Volume
159.42K
Volume159.42K
52 Week high
$5,867.53
52 Week high$5,867.53
52 Week low
$0.7044
52 Week low$0.7044

Stock Snapshot

As of today, Aditxt(ADTX) shares are valued at $0.75. The company's market cap stands at 410.69K.

During the trading session on 2026-01-15, Aditxt(ADTX) shares reached a daily high of $0.76 and a low of $0.71. At a current price of $0.75, the stock is +6.0% higher than the low and still -0.8% under the high.

Trading volume for Aditxt(ADTX) stock has reached 159.42K, versus its average volume of 256.18K.

The stock's 52-week range extends from a low of $0.70 to a high of $5,867.53.

The stock's 52-week range extends from a low of $0.70 to a high of $5,867.53.

People also own

Based on the portfolios of people who own ADTX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .